Global Stem Cell Therapy Market Size to Reach USD 554.25 Million by 2028: Brandessence Market Research

LONDON, Nov. 1, 2022 /PRNewswire/ -- Stem Cell Therapy Global Market Report 2022", grew from $ 197.30 Million in 2021 to $ 554.25 Million in 2028 at a growth rate (CAGR) of 15.90%.

Stem cell therapy is a clinical process that involves the adoption of stem cells for the prevention or treatment of various ailments. It is also referred to as regenerative medical therapy and is used by healthcare professionals to repair damaged cells. Stem cells are highly effective in treating inflammatory, neurological, autoimmune, neurological, and orthopedic conditions as they have the ability to penetrate and develop into any form of cell inside the body.

Get Sample of Report@ https://brandessenceresearch.com/requestSample/PostId/1246

Stem Cell Therapy Market: Scope

The growing pervasiveness of chronic ailments, rapidly evolving healthcare infrastructure, and rising R&D activities in the field are primarily the augmenting the outlook of this business vertical.

Furthermore, surging government initiatives to promote the adoption of stem cell therapy, technological advancements in the field along with growing medical expenditure across various regions are creating lucrative opportunities for the marketplace to prosper.

Also, increasing adoption of stem cell therapy in cancer treatment, rising geriatric population base, and favorable reimbursement scenarios across various regions are adding momentum to the progression of global stem cell therapy market.

On the contrary, rigid government regulations pertaining to the stem cell therapy along with ethical issues associated with the same are hindering the remuneration of this business vertical.

Stem Cell Therapy Market: Competitive Analysis 

The prominent players defining the competitive terrain of this market sphere are Osiris Therapeutics, Inc., MEDIPOST, Anterogen, Ltd., Cynata, Pharmicell, Cytori Therapeutics, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, NuVasive, RTI Surgical, STEMCELL Technologies, BIOTIME, Osiris Therapeutics, Human Longevity, Advanced Cell Technology, Promethera Biosciences, Mesoblast and AlloSource, and Others.

Several inorganic and organic growth strategies are being adopted by the aforementioned players for further business expansion. They are extensively emphasizing toward strengthening their competitive edge by investing on R&D activities, new products launches, mergers & acquisitions, collaborations, and partnerships, among others.

Stem Cell Therapy Market: Segmentation Analysis

By Type

• Allogeneic Stem Cell Therapy Market, By Application
• Musculoskeletal Disorders
• Wounds and Injuries
• Surgeries
• Acute Graft-Versus-Host Disease (AGVHD)
• Other Applications
• Autologous Market, By Application
• Wounds and Injuries
• Cardiovascular Diseases
• Gastrointestinal Diseases
• Other Applications
• By Therapeutic Application
• Musculoskeletal Disorders
• Wounds and Injuries
• Cardiovascular Diseases
• Surgeries
• Gastrointestinal Diseases
• Other Applications
• By Cell Source
• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells
• Other Cell Sources

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1246

Growth Analysis:

A wide array of beneficial factors is positively influencing the trends of the global stem cell therapy market.

There has been a steep rise in the pervasiveness of rare genetic diseases across the globe. Millions of individuals are diagnosed with genetic disorders such as cystic fibrosis, thalassemia, and phenylketonuria, among others. It is clinically evident that advanced cell therapies are highly effective in treating such ailments as compared to conventional medications and therapies. The ability of stem cell therapy to repair or replace damaged cell is escalating its demand across the globe.

Moreover, the world is witnessing a rapid surge in the prevalence of chronic ailments. This is powered by the hectic work schedule of the masses coupled with the adoption of unhealthy eating habits. Also, rise in alcohol consumption and excessive smoking is further leading to the occurrence of various diseases. Stem cell based treatment has proven to be effective in treating such disorders. This in turn is stimulating the overall market dynamics.

Also, government across various nations are encouraging the adoption of advanced cell therapies in the disease diagnosis and treatment sector. Concerned bodies are providing R&D centers with sufficient funds for research activities in the field. This in turn has led to the emergence of innovative cell based therapies.

Region-wise Insights:

Which is the fastest growing region in global stem cell therapy market?

North America is presently dominating the industry in terms of revenue share. This is ascribed to the growing prevalence of genetic disorders, increasing geriatric population base, and rising healthcare expenditure.

Also, favorable government incentives aimed at the development of advanced cell therapies along with rapidly evolving healthcare infrastructure are adding momentum to the North America stem cell therapy market growth.

How is Asia Pacific faring in the industry?

Asia Pacific is reckoned to generate significant returns over the stipulated timeframe. This is attributable to the growing elderly populace, presence of favorable government regulations, rising prevalence of chronic ailments, surging per capita income of the masses, along with elevating R&D activities in the field.

Category-wise Outlook:

Which type segment is currently leading this business vertical?

The allogenic stem therapy segment is poised to amass notable gains over the forecast duration owing to the widespread use of this therapy in cancer treatment. It enables the donor stem cells to use their immune system cells to further attack and destroy the cancer cells.

Which is the fastest growing therapeutic application segment in the market?

The musculoskeletal disorders segment is the fastest growing segment in the global stem cell therapy market. This is attributable to the rising occurrence of musculoskeletal disorders especially among the elderly population base.

Which cell source segment holds the most significant proportion in global stem cell therapy market?

The adipose tissue-derived stem cell segment has captured a substantial revenue share due to the wide array of benefits offered by this cell source like simple isolation process.

On Special Requirement Stem Cell Therapy Market Report is also available for below region:

North America

• U.S, Canada

Europe

• Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

• South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

• Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

• Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Stem Cell Therapy Market: Major Developments

• In January 2020, Astellas Pharma, Inc. joined hands with Allele Biotechnology and Pharmaceuticals, Inc. to jointly expand their cell therapy technology portfolio. This decision will further enable Astellas to access Allele's advanced induced pluripotent stem cell technologies.

Purchase Copy of Report @ https://brandessenceresearch.com/Checkout?report_id=1246

Related Reports:

• Global Malaria Vaccine Market is projected to decline at a CAGR of 12.3% by 2028: Brandessence Market Research
• 6.8% CAGR , Companion Animal Vaccine Market Size, Share, significant growth Rate, Trends 2028 by Brandessence Market Research
• Pneumococcal Vaccines Market Size to Hit $ 12.11 Bn, Globally, by 2028 Growing at 5.2% CAGR
• Solar Panel Coating Market Size is projected to reach USD 9.57 Billion by 2028, growing at a CAGR of 21.76%: Brandessence Market Research
• Global Specialty Coffee Market Size to Reach USD 71.21 Billion by 2028, Says Brandessence Market Research
• The Global Shea Butter Market size Is Anticipated to Rise at a CAGR of 7.60% Over the Forecast Period of 2022 To 2028, Says Brandessence Market Research
• Liquid Fertilizers Market is Projected to Reach USD 16.07 Billion by 2028 | Global Market Report 2022 to 2028, Says Brandessence Market Research
• Epoxy Coating Industry Size to Worth USD 47.14 Billion by 2028 | Market Report, Trends, Forecast & Segmentation 2022 to 2028
• Anthrax Vaccines Market Size to Surpass USD 1082.2 Million by 2028
• Global $ 6850.6 Billion Inactivated Vaccines Market is Expected to Grow at a CAGR of over 3.41% During 2022-2028 Brandessence Market Research

i-Factor: Live Market intelligence platform 

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister 

Brandessence Market Research & Consulting Pvt ltd. 

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London. 

Follow Us: Linkedin Blog:  Healthcare Revenue Cycle Management Companies

Contact: 
Mr. Vishal Sawant  
Email: vishal@brandessenceresearch.com  
Email: Sales@brandessenceresearch.com  
Corporate Sales: +44-2038074155  
Asia Office: +917447409162 

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg